ADIL (Adial Pharmaceuticals) Net Margin %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADIL Adial Pharmaceuticals Inc ADIL
30 GF Score
Price $5.94
! 1 Warning Sign
View Full Analysis

What is Adial Pharmaceuticals Net Margin %?

Adial Pharmaceuticals ADIL +2.59% 30 Net Margin % is 0.00% as of Jun. 2026. GuruFocus rates ADIL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 942 Biotechnology companies, Adial Pharmaceuticals ranks worse than 106157.01% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Adial Pharmaceuticals's Net Income for the three months ended in Jun. 2026 was $-51.99 Mil. Adial Pharmaceuticals's Revenue for the three months ended in Jun. 2026 was $0.00 Mil. Therefore, Adial Pharmaceuticals's net margin for the quarter that ended in Jun. 2026 was 0.00%.

The historical rank and industry rank for Adial Pharmaceuticals's Net Margin % or its related term are showing as below:


ADIL's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -77.59
* Ranked among companies with meaningful Net Margin % only.

Adial Pharmaceuticals  (NAS:ADIL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Adial Pharmaceuticals Net Margin % Related Terms

Adial Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Adial Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adial Pharmaceuticals Net Margin % Chart

Adial Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Adial Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ADIL vs PULM, KAPA, ACXP: Net Margin % Comparison

For the Biotechnology subindustry, Adial Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adial Pharmaceuticals Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adial Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Adial Pharmaceuticals's Net Margin % falls into.


ADIL
30GF Score
Adial Pharmaceuticals Inc ADIL
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adial Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Adial Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.977/0
= %

Adial Pharmaceuticals's Net Margin for the quarter that ended in Jun. 2026 is calculated as

Net Margin=Net Income (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-51.989/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Adial Pharmaceuticals (ADIL) has a Net Margin % of 0.00% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Adial Pharmaceuticals and its competitors. According to the industry distribution chart, Adial Pharmaceuticals ranks #999999 out of 942 companies in the Biotechnology industry.
Is Adial Pharmaceuticals' Net Margin % too high?
Adial Pharmaceuticals' current Net Margin % is 0.00%. Based on the distribution chart, Adial Pharmaceuticals ranks #999999 out of 942 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Adial Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Adial Pharmaceuticals' Net Margin % compare to PULM and KAPA?
According to the Biotechnology industry distribution chart, Adial Pharmaceuticals ranks #999999 out of 942 companies for Net Margin %. This places Adial Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Adial Pharmaceuticals and its competitors. Adial Pharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adial Pharmaceuticals stock overvalued right now?
Adial Pharmaceuticals (ADIL) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Adial Pharmaceuticals' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Adial Pharmaceuticals (ADIL), the current Net Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adial Pharmaceuticals Business Description

Address 4870 Sadler Road, Suite 300, Glen Allen, VA, USA, 23060
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
30GF Score

Get the complete analysis for ADIL

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.94
Price